SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Halozyme Therapeutics Inc., a San Diego-based biopharmaceutical company, will receive $15 million as an initial payment from Pennsylvania-based Janssen Biotech Inc. as part of a collaboration and license agreement to develop and commercialize products combining Halozyme’s technology with Janssen’s compounds.
Royal Philips NV agreed to buy San Diego-based Volcano Corp. for $1 billion to expand in catheter-based imaging of the heart and blood vessels as part of a wider refocus on more profitable markets, such as medical gear.
Downtown-based Rock My World has trotted out a new feature on its RockMyRun music app for iPhones — one that plays tunes in synch with a listener’s heartbeat.
Applied Proteomics Inc., a San Diego-based developer of protein-based molecular diagnostics, announced the appointment of Steve R. Martin as chief financial officer.
San Diego-based Biocept Inc., a molecular oncology diagnostics company, announced that it has been granted a patent in South Korea for its microfluidic channel technology used to capture circulating tumor cells.
Due to rising consumer interest in health information technology and the transition to accountable care inspired by health care reform - patient portals are everywhere.
Geneva Health Care Inc., a San Diego-based medical technology company, announced that Sharp HealthCare will begin using the Geneva Healthcare Suite, a technology platform for managing data from cardiac devices.
BIOTECH: Efforts Backed By Grant From a Foundation
San Diego 3-D bioprinting company Organovo Holdings Inc. and Yale School of Medicine, Department of Surgery have formed a collaboration to develop bioprinted tissues for surgical transplantation research, according to a recent news release.
BIOTECH: Dehydration Detection Is Leading Co. To Other Types of Sensors
Electrozyme LLC, a local startup that has attracted the financial support of Dallas Mavericks owner Mark Cuban, has developed a technology for fitness-related wearable devices that will tell users when they are nearing dehydration — and what to do about it.
Batu Biologics Inc., a biotechnology company developing a cancer vaccine that targets a tumor's blood vessels, announced the filing of an Investigational Drug Application (IND) with the U.S. Food and Drug Administration (FDA) for its lead immune therapy, ValloVax.
MEI Pharma Inc., a San Diego-based oncology company focused on clinical development of cancer therapies, announced that it plans to offer up to $45 million in shares of its common stock in an underwritten public offering.
La Jolla Pharmaceutical Co., a business developing therapies for life-threatening diseases, and George Washington University announced that they have entered into an exclusive worldwide license agreement.
UC San Diego Health Systems announced that Dr. Thomas Savides has been named chief experience officer, a newly created role for the organization.
Batu Biologics Inc., a San Diego-based immunotherapy company working to develop a cancer vaccine, announced the appointment of Gerry Berg as chief financial officer.
Geneva Health Care Inc., a San Diego-based medical technology company, announced that Sharp Healthcare will begin using the Geneva Healthcare Suite, a technology platform for managing data from cardiac devices.